Code of Federal Regulations · Subpart

Subpart G — Biotechnology Invention Disclosures

37 C.F.R. pt. 1, subpt. G

• § 1.801 Biological Material
• § 1.802 Need Or Opportunity To Make A Deposit
• § 1.803 Acceptable Depository
• § 1.804 Time Of Making An Original Deposit
• § 1.805 Replacement Or Supplement Of Deposit
• § 1.806 Term Of Deposit
• § 1.807 Viability Of Deposit
• § 1.808 Furnishing Of Samples
• § 1.809 Examination Procedures
• § 1.821 Nucleotide And/or Amino Acid Sequence Disclosures In Patent Applications
• § 1.822 Symbols And Format To Be Used For Nucleotide And/or Amino Acid Sequence Data
• § 1.823 Requirements For Content Of A “sequence Listing” Part Of The Specification
• § 1.824 Form And Format For A Nucleotide And/or Amino Acid Sequence Submission As An Ascii Plain Text File
• § 1.825 Amendment To Add Or Replace A “sequence Listing” And Crf Copy Thereof
• § 1.831 Requirements For Patent Applications Filed On Or After July 1, 2022, Having Nucleotide And/or Amino Acid Sequence Disclosures
• § 1.832 Representation Of Nucleotide And/or Amino Acid Sequence Data In The “sequence Listing Xml” Part Of A Patent Application Filed On Or After July 1, 2022
• § 1.833 Requirements For A “sequence Listing Xml” For Nucleotide And/or Amino Acid Sequences As Part Of A Patent Application Filed On Or After July 1, 2022
• § 1.834 Form And Format For Nucleotide And/or Amino Acid Sequence Submissions As The “sequence Listing Xml” In Patent Applications Filed On Or After July 1, 2022
• § 1.835 Amendment To Add Or Replace A “sequence Listing Xml” In Patent Applications Filed On Or After July 1, 2022
• § 1.839 Incorporation By Reference